Balance assessment in selected stages of Parkinson's disease using trend change analysis.
Piotr Wodarski, Jacek Jurkojć, Justyna Michalska and 3 others
PMID 37528430WHAT IT FOUND
A new balance metric called the Trend Change Index (TCI) successfully distinguished Parkinson's patients from healthy controls in both early and later stages.
Unlike standard speed measurements, this metric detected balance differences in Stage II patients who otherwise looked normal on traditional tests.
Key findings
01The Trend Change Index (TCI) was significantly higher in patients with Stage II and Stage III Parkinson's disease compared to age-matched healthy controls.
02Standard center of pressure (COP) velocity did not distinguish Stage II Parkinson's patients from age-matched controls, but the TCI did.
03The TCI showed high reliability and repeatability in the study participants.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study groups were small, particularly the Parkinson's cohorts (15 per stage), which limited the ability to confirm all hypotheses. The study did not compare the new TCI metric against standard clinical balance tests like the Berg Balance Scale or Timed Up and Go. The analysis assumed no significant differences between men and women, which the authors note may not be true. The study did not include patients with Stage I or Stage IV/V Parkinson's disease, so it does not cover the full spectrum of the condition.
Declared interests
The authors declared no competing interests. The study was supported by non-U.S. government funding.
The easy way to misread this
Do not assume this new metric is ready for clinical use or that it replaces standard balance tests. The study was small, did not validate the TCI against common clinical scales like the Berg Balance Scale, and only included patients in Stages II and III.